Next Article in Journal
Propolis as a Cariostatic Agent in Lozenges and Impact of Storage Conditions on the Stability of Propolis
Next Article in Special Issue
Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
Previous Article in Journal
Shining a Light on Prostate Cancer: Photodynamic Therapy and Combination Approaches
Previous Article in Special Issue
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 6
10.3390/pharmaceutics15061769
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2023, 15(2), 682.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682

by
Aleksandr Kazimir
1,
Benedikt Schwarze
2,
Peter Lönnecke
1,
Sanja Jelača
3,
Sanja Mijatović
3,
Danijela Maksimović-Ivanić
3 and
Evamarie Hey-Hawkins
1,*
1
Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany
2
Institute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, 04107 Leipzig, Germany
3
Department of Immunology, Institute for Biological Research “Siniša Stanković”, National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(6), 1769; https://doi.org/10.3390/pharmaceutics15061769
Submission received: 25 May 2023 / Accepted: 30 May 2023 / Published: 19 June 2023
(This article belongs to the Special Issue Recent Advances in the Development of Hybrid Drugs)
Browse Figure
Versions Notes

Error in Scheme 1

In the original publication [1], there was an error in Scheme 1 as published. Scheme 1 was cut off at the left-hand side. The error happened during the final stage of publishing by the journal, and the authors provided the proper version in the corrected proof. The corrected Scheme 1 appears below.
Pharmaceutics 15 01769 sch001 550
Scheme 1. Incorporation of the nido-carborate dianion in 2,2′-bipyridine complexes: (A) initial formation of metallacarboranes (not shown) followed by reaction with ligand 4; (B) initial formation of metal(II) dichloride complexes 5 and 6 followed by reaction with Tl [closo-TlC2B9H11] for chloride replacement.
Scheme 1. Incorporation of the nido-carborate dianion in 2,2′-bipyridine complexes: (A) initial formation of metallacarboranes (not shown) followed by reaction with ligand 4; (B) initial formation of metal(II) dichloride complexes 5 and 6 followed by reaction with Tl [closo-TlC2B9H11] for chloride replacement.
Pharmaceutics 15 01769 sch001
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Kazimir, A.; Schwarze, B.; Lönnecke, P.; Jelača, S.; Mijatović, S.; Maksimović-Ivanić, D.; Hey-Hawkins, E. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kazimir, A.; Schwarze, B.; Lönnecke, P.; Jelača, S.; Mijatović, S.; Maksimović-Ivanić, D.; Hey-Hawkins, E. Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682. Pharmaceutics 2023, 15, 1769. https://doi.org/10.3390/pharmaceutics15061769

AMA Style

Kazimir A, Schwarze B, Lönnecke P, Jelača S, Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682. Pharmaceutics. 2023; 15(6):1769. https://doi.org/10.3390/pharmaceutics15061769

Chicago/Turabian Style

Kazimir, Aleksandr, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, and Evamarie Hey-Hawkins. 2023. "Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682" Pharmaceutics 15, no. 6: 1769. https://doi.org/10.3390/pharmaceutics15061769

APA Style

Kazimir, A., Schwarze, B., Lönnecke, P., Jelača, S., Mijatović, S., Maksimović-Ivanić, D., & Hey-Hawkins, E. (2023). Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682. Pharmaceutics, 15(6), 1769. https://doi.org/10.3390/pharmaceutics15061769

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop